Medication Overuse Headache

被引:0
作者
Valerie Cheung
Farnaz Amoozegar
Esma Dilli
机构
[1] University of British Columbia,Gordon and Leslie Diamond Health Center
[2] University of Calgary,8219
来源
Current Neurology and Neuroscience Reports | 2015年 / 15卷
关键词
Medication overuse headache; Rebound headache; Chronic daily headache; Opioids; Triptans; Combination analgesics; NSAIDS;
D O I
暂无
中图分类号
学科分类号
摘要
Medication overuse headache (MOH) is a common and disabling headache disorder. It has a prevalence of about 1–2 % in the general population. The International Classification of Headache Disorders 3rd edition (beta version) has defined MOH as a chronic headache disorder in which the headache occurs on 15 or more days per month due to regular overuse of medication. These headaches must have been present for more than 3 months. The pathophysiology is complex and not completely known. It involves genetic and behavioural factors. There is evidence that cortical spreading depression, trigeminovascular system and neurotransmitters contribute to the pain pathway of MOH. The treatment of MOH includes patient education, stopping the offending drug(s), rescue therapy for withdrawal symptoms and preventative therapy. Relapse rates for MOH are high at 41 %. MOH can severely impact quality of life, so it is important to identify patients who are at risk of analgesic overuse.
引用
收藏
相关论文
共 247 条
  • [1] Peters GA(1951)Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects Proc Staff Meet Mayo Clin 26 153-61
  • [2] Horton BT(1963)Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases Headache 2 214-27
  • [3] Horton BT(2010)Clinical features, pathophysiology, and treatment of medication-overuse headache Lancet Neurol 9 391-401
  • [4] Peters GA(2011)Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review Cephalalgia 31 837-50
  • [5] Evers S(2014)Clinical aspects of medication overuse headaches Headache 54 211-7
  • [6] Marziniak M(2004)Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life Neurology 62 1338-42
  • [7] Lanteri-Minet M(2013)Medication-overuse headache Curr Opin Neurol 26 276-81
  • [8] Duru G(2012)The prevalence of primary headache disorders in Russia: a countrywide survey Cephalalgia 32 373-81
  • [9] Mudge M(2013)Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010 Neurol Sci 34 1157-66
  • [10] Cottrell S(2011)Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3) Cephalalgia 31 585-96